Last reviewed · How we verify

Gonal -f® [r-hFSH]

Merck KGaA, Darmstadt, Germany · FDA-approved active Small molecule Quality 2/100

Gonal -f® [r-hFSH] is a Small molecule drug developed by Merck KGaA, Darmstadt, Germany. It is currently FDA-approved. Also known as: Gonal-f®, Follitropin Alfa.

At a glance

Generic nameGonal -f® [r-hFSH]
Also known asGonal-f®, Follitropin Alfa
SponsorMerck KGaA, Darmstadt, Germany
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Gonal -f® [r-hFSH]

What is Gonal -f® [r-hFSH]?

Gonal -f® [r-hFSH] is a Small molecule drug developed by Merck KGaA, Darmstadt, Germany.

Who makes Gonal -f® [r-hFSH]?

Gonal -f® [r-hFSH] is developed and marketed by Merck KGaA, Darmstadt, Germany (see full Merck KGaA, Darmstadt, Germany pipeline at /company/merck-kgaa-darmstadt-germany).

Is Gonal -f® [r-hFSH] also known as anything else?

Gonal -f® [r-hFSH] is also known as Gonal-f®, Follitropin Alfa.

What development phase is Gonal -f® [r-hFSH] in?

Gonal -f® [r-hFSH] is FDA-approved (marketed).

Related